← Back to Search

Other

Exercise for Vision Impairment

N/A
Waitlist Available
Led By Jeffrey H. Boatright, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 18 to 89
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

This trial will see if certain bodily changes can predict if exercise will help save someone's vision.

Who is the study for?
This trial is for English-speaking adults aged 18 to 89 who are mostly inactive, doing less than 120 minutes of aerobic exercise per week over the last three months. Participants should not have dementia (with an MMSE score of at least 24) and cannot join if they have severe diabetes requiring insulin or cognitive-executive function deficits (MoCA score below 26).Check my eligibility
What is being tested?
The study is testing whether regular aerobic and balance exercises can improve vision in people with visual impairments. It will also look at changes in blood biomarkers to see if they can predict the benefits of exercise on vision.See study design
What are the potential side effects?
While specific side effects are not detailed, typical risks associated with aerobic and balance exercises may include muscle soreness, fatigue, falls, or injury. The intensity of these side effects varies from person to person.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 89 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Contrast sensitivity
Retinal morphology
Visual acuity
+1 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Aerobic ExerciseActive Control1 Intervention
Exercise 3 times a week
Group II: Balance TrainingPlacebo Group1 Intervention
Group balance training 3 times a week

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,583 Total Patients Enrolled
Jeffrey H. Boatright, PhDPrincipal InvestigatorAtlanta VA Medical and Rehab Center, Decatur, GA

Media Library

Aerobic exercise (Other) Clinical Trial Eligibility Overview. Trial Name: NCT02911805 — N/A
Vision Impairment Research Study Groups: Aerobic Exercise, Balance Training
Vision Impairment Clinical Trial 2023: Aerobic exercise Highlights & Side Effects. Trial Name: NCT02911805 — N/A
Aerobic exercise (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02911805 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research restricted to those aged 85 and under?

"To be eligible for this medical experiment, individuals must have surpassed the age of majority and not yet reached their eightieth year."

Answered by AI

Who has the privilege of participating in this clinical experiment?

"This investigation seeks 20 mature adults, ranging from 18 to 89 years of age, with a diagnosis of micropsia. Further prerequisites for enrolment include mental acuity (MMSE 24) and an established sedentary lifestyle (< 120 min/week aerobic exercise in the last 3 months)."

Answered by AI

Is recruitment still open for the trial participants?

"Contrary to expectation, clinicaltrials.gov reports that this trial is presently not seeking participants; the post was initially published on June 10th 2015 and last updated on June 14th 2022. However, there are 44 other trials actively recruiting patients as of now."

Answered by AI
~2 spots leftby Apr 2025